<DOC>
	<DOCNO>NCT02057757</DOCNO>
	<brief_summary>Respiratory virus significant cause hospitalization respiratory tract infection . This study evaluate safety , effectiveness , tolerability nitazoxanide ( NTZ ) treat severe acute respiratory illness ( SARI ) people hospitalize .</brief_summary>
	<brief_title>Evaluating Safety , Effectiveness , Tolerability Nitazoxanide Addition Standard Care Treatment Severe Acute Respiratory Illness People Who Are Hospitalized</brief_title>
	<detailed_description>Respiratory viral infection one common cause illness world . These infection major cause SARI lead severe outcome , include hospitalization death . NTZ medication approve United States Mexico treat gastrointestinal parasitic disease . This study evaluate use NTZ treat SARI . The purpose study evaluate safety , effectiveness , tolerability NTZ , combination standard care , treat SARI people hospitalize . Participants hospitalize study entry assessment include medical assessment , blood collection , nasopharyngeal swab wash . Participants randomly assign receive NTZ placebo 5 day . Participants young 12 year receive oral suspension formulation NTZ placebo ; participant 12 year older receive NTZ placebo tablet . All participant also receive standard care treatment acute severe viral respiratory infection , may include antibiotic and/or treatment influenza . They discharge hospital base doctor ' recommendation . Participants record temperature symptom daily diary , review study staff study visit . Follow-up visit occur Days 3 , 7 , 14 , 28 , may occur inpatient outpatient visit . These visit may include assessment occurred baseline , well physical examination , depend visit . Participants still hospitalize Day 28 follow study staff discharge hospital .</detailed_description>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Signed informed consent prior performance initiation study procedure Age great equal 12 month age ( upper age limit ) Influenzalike illness ( ILI ) , define ( follow ) : Onset fever great equal 38°C ( hypothermia le 36°C ) New bad cough sore throat New bad shortness breath difficulty breathe Onset illness 5 day screen define participant experience least 1 respiratory symptom , constitutional symptom , fever Hospitalization ILI ( decision hospitalization individual treating clinician ) , anticipate hospitalization 24 hour One follow avoid pregnancy : Females able become pregnant ( i.e. , postmenopausal , undergone surgical sterilization , sexually active men ) must agree use least 1 effective form contraception date informed consent Day 28 study Males undergone surgical sterilization sexually active woman must agree use condom partner use least 1 effective form contraception Day 28 study Women pregnant breastfeed Clinical suspicion etiology illness primarily bacterial origin Prior treatment antiviral ( e.g. , oseltamivir ) current illness 24 hour Unable take oral medication ( adult must tolerate tablet , child must tolerate suspension ) Unable tolerate oral food/fluids ( absorption significantly well food ) Prior treatment investigational drug therapy within 30 day prior screen Known sensitivity NTZ excipients comprise NTZ tablet Prior NTZ use within 1 week Selfreported history chronic kidney disease impair renal function ( blood urine kidney function laboratory test do prior enrollment , intent exclude disease severe enough cause estimate creatinine clearance [ CrCl ] le 30 ) Selfreported history liver disease ( blood laboratory test do prior enrollment , intent exclude disease severe enough cause cirrhosis total bilirubin great 2 , aspartate aminotransferase [ AST ] /alanine aminotransferase [ ALT ] great 3 time upper limit normal [ ULN ] ) Presence preexist illness , opinion investigator , would place participant unreasonably increase risk participation study Participants , judgment investigator , unlikely comply requirement protocol The onset SARI occur hospitalization Hospitalized reason great 48 hour prior enrollment Participants previously enrol study Prior hospital discharge within 30 day Known chronic respiratory infection ( e.g. , tuberculosis , atypical mycobacterial infection )</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>